抗IL-1 Receptor Antagonist抗体(Anti-IL-1 Receptor Antagonist, Human, Mouse-Mono antibody)

掲載日情報:2021/01/28 現在Webページ番号:28246

IL-1 Receptor Antagonistに対する抗体(Anti-IL-1 Receptor Antagonist, Human, Mouse-Mono )です。
本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2024年06月02日 00時00分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Anti-IL-1 Receptor Antagonist, Human, Mouse-Mono(10309.211) <Anti-IL-1RA>
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 10
  • 使用文献
  • メーカーサイト
  • お問い合わせ
説明文
マッチドペア:Human IL-1ra/IL-1F3 サンドイッチELISAの補足用抗体として利用可能,検出用抗体として#BAF280,スタンダードとして#280-RA-010を用いる。
別名:DIRA
クローン:10309
Genbank No: 3557
Protein Accession No: P18510
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 Human 免疫動物 Mouse クラス IgG 標識 Unlabeled
交差性 Human 適用 ELISA,Neutralising
クロナリティ Monoclonal フォーマット 性状 Protein A/G Affinity Purified 吸収処理
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
Helper T Cells Marker Antibodies
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド
Anti-Human IL-1ra/IL-1F3 MAb (Clone 10309)
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 1
  • 使用文献
  • メーカーサイト
  • お問い合わせ
説明文
※受注発注品。形状:溶液または凍結乾燥
別名:DIRA
クローン:10309
Genbank No: 3557
Protein Accession No: P18510
別包装品 別包装品あり
法規制等
保存条件 法規備考
抗原種 免疫動物 Mouse クラス IgG 標識 Unlabeled
交差性 Human 適用 ELISA,Neutralising
クロナリティ Monoclonal フォーマット 性状 Protein A/G Affinity Purified 吸収処理
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
Helper T Cells Marker Antibodies
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド

[在庫・価格 :2024年06月02日 00時00分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Anti-IL-1 Receptor Antagonist, Human, Mouse-Mono(10309.211) <Anti-IL-1RA>

文献数: 10

説明文 マッチドペア:Human IL-1ra/IL-1F3 サンドイッチELISAの補足用抗体として利用可能,検出用抗体として#BAF280,スタンダードとして#280-RA-010を用いる。
別名:DIRA
クローン:10309
Genbank No: 3557
Protein Accession No: P18510
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 Human 免疫動物 Mouse
交差性 Human 適用 ELISA,Neutralising
標識 Unlabeled 性状 Protein A/G Affinity Purified
吸収処理 クラス IgG
クロナリティ Monoclonal フォーマット
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
Helper T Cells Marker Antibodies
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド

Anti-Human IL-1ra/IL-1F3 MAb (Clone 10309)

文献数: 1

説明文 ※受注発注品。形状:溶液または凍結乾燥
別名:DIRA
クローン:10309
Genbank No: 3557
Protein Accession No: P18510
別包装品 別包装品あり
法規制等
保存条件 法規備考
抗原種 免疫動物 Mouse
交差性 Human 適用 ELISA,Neutralising
標識 Unlabeled 性状 Protein A/G Affinity Purified
吸収処理 クラス IgG
クロナリティ Monoclonal フォーマット
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
Helper T Cells Marker Antibodies
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド



目次に戻る

Product Details

Species ReactivityHuman
LabelUnconjugated
ImmunogenE. coli-derived recombinant human IL‑1ra/IL-1F3Arg26-Glu177Accession # P18510
SourceMonoclonal Mouse IgG2A Clone # 10309
PurificationProtein A or G purified from ascites
SpecificityDetects human IL‑1ra/IL-1F3 in ELISAs. In ELISAs, this antibody shows less than 0.2% cross-reactivity with recombinant mouse (rm) IL‑1ra and no cross-reactivity with rhIL‑1 alpha, rpIL‑1 alpha, rmIL‑1 alpha, rrIL‑1 alpha, rhIL‑1 beta, rpIL‑1 beta, rmIL‑1 beta, rrIL‑1 beta, rhIL‑1 RI, or rhIL‑1 RII.


目次に戻る

Applications and Data

 Recommended
Concentration
Sample
Human IL-1ra/IL-1F3 Sandwich ImmunoassayReagent
ELISA Capture (Matched Antibody Pair)2-8 µg/mL Human IL‑1ra/IL‑1F3 Antibody (Catalog #MAB280 )
ELISA Detection (Matched Antibody Pair)0.1-0.4 µg/mL Human IL‑1ra/IL‑1F3 Biotinylated Antibody (Catalog #BAF280 )
ELISA Standard  Recombinant Human IL-1ra/IL-1F3 Protein (Catalog #280-RA )
NeutralizationMeasured by its ability to neutralize IL‑1ra/IL‑1F3 inhibition of IL‑1 alpha /IL‑1F1-dependent proliferation in the D10.G4.1 mouse helper T cell line. Symons, J.A. et al. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 272. The Neutralization Dose (ND50) is typically 10-20 µg/mL in the presence of 50 ng/mL Recombinant Human IL‑1ra/IL‑1F3, 50 pg/mL Recombinant Human IL‑1 alpha /IL‑1F1 and 1.25 µg/mL concanavalin A.
Please Note: Optimal dilutions should be determined by each laboratory for each application.General Protocolsare available in the Technical Information section on our website.

目次に戻る

Data Examples

Neutralization Neutralization IL-1ra/IL-1F3/IL1RN Antibody (10309)
click image to view larger
IL‑1ra/IL‑1F3 Inhibition of IL‑1 alpha /IL‑1F1-dependent Cell Proliferation and Neutralization by Human IL‑1ra/IL‑1F3 Antibody.Recombinant Human IL‑1ra/IL‑1F3 (Catalog # 280-RA) inhibits Recombinant Human IL‑1 alpha /IL‑1F1 (Catalog # 200-LA) induced proliferation in the D10.G4.1 mouse helper T cell line in a dose-dependent manner (orange line). Inhibition of Recombinant Human IL‑1 alpha /IL‑1F1 (50 pg/mL) activity elicited by Recombinant Human IL‑1ra/IL‑1F3 (50 ng/mL) is neutralized (green line) by increasing concentrations of Human IL‑1ra/IL‑1F3 Monoclonal Antibody (Catalog # MAB280). The ND50 is typically 10-20 µg/mL in the presence of concanavalin A (1.25 µg/mL).
ReconstitutionReconstitute at 0.5 mg/mL in sterile PBS.Reconstitution Buffer Available
ShippingThe product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IL-1ra/IL-1F3

IL-1ra was originally isolated from the urine of patients with monocytic leukemia and has also been purified from adherent monocytes. The naturally occurring, fully glycosylated form has an apparent molecular weight of about 25,000 Daltons. The protein shows 26% amino acid homology to IL-1 beta and 19% homology to IL-1 alpha. It will compete with either factor for receptor binding, but does not interact with either one. Human IL-1ra will bind to both types of IL-1 receptor (I and II) on human cells, but reportedly will not block binding to the type II receptor on murine pre-B cell lines. The recombinant, non-glycosylated form of IL-1ra blocks binding of IL-1 to its receptor equally as well as the naturally-occurring, glycosylated form. The IL-1ra has been shown to block the inflammatory responses induced by IL-1 both in vitro and in vivo. Currently, pre-clinical and clinical studies are underway to test possible therapeutic applications for IL-1ra in the treatment of sepsis, rheumatoid arthritis and chronic myelogenous leukemia.

Long Name:Interleukin 1 Receptor Antagonist
Entrez Gene IDs:3557 (Human); 16181 (Mouse); 60582 (Rat); 397499 (Porcine)
Alternate Names:DIRA; ICIL-1RA; IL1F3; IL-1F3; IL1ra; IL-1ra; IL-1ra3; IL1RN; IL-1RN; interleukin 1 receptor antagonist; IRAP; MVCD4

目次に戻る

Related Research Areas

Show
Cytokine and Growth Factor Receptors on VSMC
Cytokines and Receptors in Allergy and Asthma
Cytokines and Receptors in Angiogenesis
IL-1 Family
Macrophage Activation Markers
Neuroinflammation
  1. Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines
    Authors: Damien Dietrich
    Cytokine, 2016;84(0):88-98.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut
ImagesRatingsApplicationsSpeciesReviewed ByDateDetails
Very Good
 Simple Western Mouse Anonymous 04/05/2018

目次に戻る

Summary

Show
Application Simple Western
Sample Tested B16-F1 mouse melanoma cell line
Species Mouse
Excellent
 Siteclick antibody biotinylation Mouse Anonymous 10/27/2017

目次に戻る

Summary

Application Siteclick antibody biotinylation
Sample Tested 3T3-L1 mouse embryonic fibroblast adipose-like cell line
Species Mouse


Neutralization
IL‑1ra/IL‑1F3 Inhibition of IL‑1 alpha /IL‑1F1-dependent Cell Proliferation and Neutralization by Human IL‑1ra/IL‑1F3 Antibody.
Recombinant Human IL‑1ra/IL‑1F3 (Catalog # 280-RA) inhibits Recombinant Human IL‑1 alpha /IL‑1F1 (Catalog # 200-LA) induced proliferation in the D10.G4.1 mouse helper T cell line in a dose-dependent manner (orange line). Inhibition of Recombinant Human IL‑1 alpha /IL‑1F1 (50 pg/mL) activity elicited by Recombinant Human IL‑1ra/IL‑1F3 (50 ng/mL) is neutralized (green line) by increasing concentrations of Human IL‑1ra/IL‑1F3 Monoclonal Antibody (Catalog # MAB280). The ND50 is typically 10-20 µg/mL in the presence of concanavalin A (1.25 µg/mL).


目次に戻る

Related Product & Information

Long NameInterleukin 1 Receptor Antagonist
Entrez Gene IDs3557 (Human); 16181 (Mouse); 60582 (Rat); 397499 (Porcine)
BackgroundIL-1ra/IL-1F3
background_contentBackground:
IL-1ra/IL-1F3
IL-1ra was originally isolated from the urine of patients with monocytic leukemia and has also been purified from adherent monocytes. The naturally occurring, fully glycosylated form has an apparent molecular weight of about 25,000 Daltons. The protein shows 26% amino acid homology to IL-1 beta and 19% homology to IL-1 alpha. It will compete with either factor for receptor binding, but does not interact with either one. Human IL-1ra will bind to both types of IL-1 receptor (I and II) on human cells, but reportedly will not block binding to the type II receptor on murine pre-B cell lines. The recombinant, non-glycosylated form of IL-1ra blocks binding of IL-1 to its receptor equally as well as the naturally-occurring, glycosylated form. The IL-1ra has been shown to block the inflammatory responses induced by IL-1 both in vitro and in vivo. Currently, pre-clinical and clinical studies are underway to test possible therapeutic applications for IL-1ra in the treatment of sepsis, rheumatoid arthritis and chronic myelogenous leukemia.


目次に戻る

Citations

R&D Systems personnel manually curate a database that contains references using R&D Systems products.The data collected includes not only links to publications in PubMed,but also provides information about sample types, species, and experimental conditions.
  1. Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines
    Authors: Damien Dietrich
    Cytokine, 2016;84(0):88-98.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut

  2. Suppression of TNF-alpha and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27.
    Authors: Kalliolias GD, Gordon RA, Ivashkiv LB
    J. Immunol., 2010;185(11):7047-56.
    Species: Human
    Sample Type: Cell Culture Supernates
    Application: ELISA Development

  3. Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1).
    Authors: Palmer G, Trolliet S, Talabot-Ayer D, Mezin F, Magne D, Gabay C
    Cytokine, 2005;31(2):153-60.
    Species: Human
    Sample Type: Whole Cells
    Application: ICC

  4. trans fatty acids and systemic inflammation in heart failure.
    Authors: Mozaffarian D, Rimm EB, King IB, Lawler RL, McDonald GB, Levy WC
    Am. J. Clin. Nutr., 2004;80(6):1521-5.
    Species: Human
    Sample Type: Plasma
    Application: ELISA Development

  5. Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokines.
    Authors: Copeland S, Siddiqui J, Remick D
    J. Immunol. Methods, 2004;284(1):99-106.
    Species: Human
    Sample Type: Cell Culture Supernates
    Application: Array Development



目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。